Guggenheim Maintains Buy on Universal Health Services, Lowers Price Target to $211

Benzinga Newsdesk www.benzinga.com Negative 59.3%

Neg 59.3% Neu 0% Pos 0%

Guggenheim analyst Jason Cassorla maintains Universal Health Services (NYSE:UHS) with a Buy and lowers the price target from $238 to $211.